The European Commission's Opinion Backing Use of Non-Human Primates is Flawed
This article was originally published in SRA
A recent opinion of the European Commission’s Scientific Committee on Health and Environmental Risks (SCHER) that supports the use of non-human primates (NHPs) in biomedical research is scientifically flawed. It fails to evaluate in a critical manner the contributions to biomedical science that the committee assumes are made by NHP research and simply disregards proof of the contribution that human biology-based methods are now able to make.
You may also be interested in...
A report from the US FDA says the agency will focus on updating its premarket submission portal, training staff and taking additional steps to start taking in applications for ASCA pilot participant sponsors.
With a late-stage compound on its hands, MGB is currently in discussions with several biotech and pharma companies and also with venture capitalists to continue late-stage development of a novel antibiotic which could transform treatment of Clostridium difficile.
AZ and the EU are at loggerheads over supplies of the COVID-19 vaccine. On top of that, its marketing authorization will present dilemmas.